Literature DB >> 4218114

Ocular histoplasmosis syndrome in the United Kingdom.

R A Braunstein, D A Rosen, A C Bird.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4218114      PMCID： PMC1215054          DOI： 10.1136/bjo.58.11.893

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  14 in total

1.  SPECIFIC OCULAR UVEAL LESIONS IN PATIENTS WITH EVIDENCE OF HISTOPLASMOSIS.

Authors:  T E VAN METRE; A E MAUMENEE
Journal:  Arch Ophthalmol       Date:  1964-03

2.  Further evaluation of amphotericin-B therapy in presumptive histoplasmosis chorioretinitis.

Authors:  C L GILES; H F FALLS
Journal:  Am J Ophthalmol       Date:  1961-04       Impact factor: 5.258

3.  Granulomatous uveitis: an etiologic survey of 100 cases.

Authors:  T F SCHLAEGEL
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1958 Nov-Dec

4.  Ocular manifestation of histoplasmosis.

Authors:  A C KRAUSE; W G HOPKINS
Journal:  Am J Ophthalmol       Date:  1951-04       Impact factor: 5.258

5.  Experimental ocular histoplasmosis.

Authors:  R DAY
Journal:  Am J Ophthalmol       Date:  1949-10       Impact factor: 5.258

6.  Presumed ocular histoplasmosis. I. Histoplasmin skin test sensitivity in cases identified during a community survey.

Authors:  R E Smith; J P Ganley
Journal:  Arch Ophthalmol       Date:  1972-03

7.  Serologic studies of presumed histoplasmic choroiditis.

Authors:  T Suie; M S Rheins; T A Makley
Journal:  Am J Ophthalmol       Date:  1965-12       Impact factor: 5.258

8.  Worldwide pattern of skin sensitivity to histoplasmin.

Authors:  P Q Edwards; E L Billings
Journal:  Am J Trop Med Hyg       Date:  1971-03       Impact factor: 2.345

9.  Histoplasma capsulatum in a human eye.

Authors:  K L Hoefnagels; P M Pijpers
Journal:  Am J Ophthalmol       Date:  1967-04       Impact factor: 5.258

10.  The status of presumed ocular histoplasmosis: including a report of a survey.

Authors:  T Asbury
Journal:  Trans Am Ophthalmol Soc       Date:  1966
View more
  12 in total

1.  Aetiological study of the presumed ocular histoplasmosis syndrome in the Netherlands.

Authors:  J V Ongkosuwito; L M Kortbeek; A Van der Lelij; E Molicka; A Kijlstra; M D de Smet; M S Suttorp-Schulten
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

2.  Presumed ocular histoplasmosis in The Netherlands--an area without histoplasmosis.

Authors:  M S Suttorp-Schulten; J G Bollemeijer; P J Bos; A Rothova
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

3.  Idiopathic sub-retinal neovascular membranes in the macula (hemorrhagic macular choroidopathy of young adults). Clinical report and effectiveness of laser treatment.

Authors:  F G Bottoni; A F Deutman
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

4.  Presumed ocular histoplasmosis syndrome and linear streak lesions.

Authors:  F G Bottoni; A F Deutman; A L Aandekerk
Journal:  Br J Ophthalmol       Date:  1989-07       Impact factor: 4.638

5.  Editorial: Presumed ocular histoplasma syndrome.

Authors: 
Journal:  Br J Ophthalmol       Date:  1974-11       Impact factor: 4.638

6.  Natural history and prognosis of choroidal neovascularization.

Authors:  J J De Laey
Journal:  Doc Ophthalmol       Date:  1983-02-28       Impact factor: 2.379

7.  Polymorphous presentations in vitelliform macular dystrophy: subretinal neovascularisation and central choroidal atrophy.

Authors:  K G Noble; B M Scher; R E Carr
Journal:  Br J Ophthalmol       Date:  1978-08       Impact factor: 4.638

8.  De novo lesions in presumed ocular histoplasmosis-like syndrome.

Authors:  S A Miller; T S Stevens; G de Venecia
Journal:  Br J Ophthalmol       Date:  1976-10       Impact factor: 4.638

9.  A case of macular subretinal neovascularisation in chronic uveitis probably caused by sarcoidosis.

Authors:  H A Hoogstede; A C Copper
Journal:  Br J Ophthalmol       Date:  1982-08       Impact factor: 4.638

10.  Association of juvenile disciform maculopathy with HLA B15.

Authors:  A Craandijk; G M Schreuder
Journal:  Br J Ophthalmol       Date:  1979-10       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.